A Study to Evaluate if New Tests (“biomarkers”) of Blood, Stool, Pancreas Cyst Fluid, or Pancreas Juice can be Used to Diagnose Malignant or Pre-malignant Changes in People with Pancreas Cysts

Overview

About this study

The goal of this protocol is to collect biospecimens in order to prospectively evaluate diagnostic and prognostic performance of MDMs for detection of advanced neoplasia in pancreatic cysts.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

- Patients with pancreatic cystic lesions meeting Fukuoka worrisome or Fukuoka high-risk
criteris

- Patients with suspected cystic neoplasm of the pancreas

- Able to provide written informed consent

Exclusion Criteria:

- Pregnant and/or nursing

- Incarceration

- Imaging showing possible pancreatic cancer

- Prior history of pancreatic cancer or pancreatic surgery

- History of receiving systemic chemotherapy or abdominal radiation within the last 5
years

- Previous therapy for a pancreatic cystic lesion

- History of pancreatic necrosis

- Diagnosis of cancer (other than non-melanoma skin cancer) within the last 5 years

Note: Other protocol defined Inclusion/Exclusion criteria may apply.

Eligibility last updated 11/27/23. Questions regarding updates should be directed to the study team contact.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location	Status	Contact
Rochester, Minn. Mayo Clinic principal investigator Shounak Majumder, M.D.	Open for enrollment	Contact information: Lucille Anderson (507) 538-5627 Anderson.Luci@mayo.edu

Mayo Clinic Location

Status

Contact

Rochester, Minn.

Mayo Clinic principal investigator

Shounak Majumder, M.D.

Open for enrollment

Contact information:

Lucille Anderson

(507) 538-5627

Anderson.Luci@mayo.edu

More information

Publications

Publications are currently not available

Clinical Trials